1297650

Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany — FEI 2211084

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 8, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Whippany, NJ (United States)